For adults with endometriosis-associated pain, what are the benefits and harms of daily oral progestogens compared with gonadotropin-releasing hormone (GnRH) agonists?

Sera Tort
In: Cochrane Clinical Answers · 2026 · doi:10.1002/cca.4855 · W7214565153
OA: closed CC0
Limited metadata. Only one source feed has indexed this record so far — no abstract, full text, or open-access copy is available through Endo Lab. The publisher's page (linked below) is the canonical location for the actual content. If you have institutional access, use "Find at my library".
View at publisher → View on OpenAlex
⚙ AI-generated summary by qwen3.7-flash, 2026-10-07 ⓘ

This paper compares the benefits and harms of daily oral progestogens versus gonadotropin-releasing hormone agonists for managing pain in adults with endometriosis.

One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works

My notes (saved in your browser only)

Citation neighborhood (sparse)

Too few in-corpus citations on either side for a chart; here are the lists.

Cites (1)

References (1)

Source provenance

openalex
last seen: 2026-10-15T06:00:39.803327+00:00
License: CC0 · commercial use OK